Zuo Jun Zou
Founder en BEIJING STRONG BIOTECHNOLOGIES,INC. .
Fortuna: 105 M $ al 31/03/2024
Cargos activos de Zuo Jun Zou
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Chairman | 29/03/2001 | - |
| Founder | 29/03/2001 | - | |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Chairman | 05/01/2022 | - |
| Director/Board Member | 15/09/2020 | 05/01/2022 |
Historial de carrera de Zuo Jun Zou
Formación de Zuo Jun Zou.
| Chinese Academy of Sciences | Graduate Degree |
| East China University of Science & Technology | Undergraduate Degree |
| Research Center For Eco Env Chinese Academy | Doctorate Degree |
Estadísticas
Internacional
| China | 6 |
Operativa
| Chairman | 2 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 4 |
| Health Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Bolsa de valores
- Insiders
- Zuo Jun Zou
- Experiencia
